Health

Verano to Report Third Quarter 2025 Financial Results on October 29, 2025

CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a…

3 months ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund…

3 months ago

Dimora PHMB Skin and Wound Cleanser – Gentle for Kids, Trusted by Parents

SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud to introduce its newest innovation, the Dimora PHMB…

3 months ago

Press release: Availability of the Q3 2025 Aide mmoire

Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025. Sanofi announced today that its Q3 2025…

3 months ago

Labviva Kicks Off Smart Lab of the Future Tour

BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI-powered procurement platform for life sciences, today announced the launch…

3 months ago

Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00…

3 months ago

Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE Rollout

Ad hoc announcement pursuant to Art. 53 LR Highlights: Santhera secures approximately CHF 20 million of additional funding from existing…

3 months ago

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening September 22, 2025…

3 months ago

Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index

September 22, 2025 09:00 ET  | Source: Carlsmed CARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL)…

3 months ago

AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth

OCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that…

3 months ago